Long-term survival (superior to 20 years) after pancreaticoduodenectomy for pancreatic duct adenocarcinoma: report of two cases.
Pancreatic duct adenocarcinoma (PDA) is associated with dismal survival. This study reports two cases of very long survival after pancreatectomy for PDA. These were two male patients with pT30M0 and pT2N0M0 tumour. Both received adjuvant treatment and are currently alive after 21y 6 months and 22 y 2 months respectively. Very long term survival for PDA can be achieved for some patients who benefit from R0 resection.
Naseef
O
O
Department of Digestive Surgery and Liver Transplantation, Edouard Herriot Hospital, Lyon, France.
Adham
M
M
Hervieu
V
V
Le Borgne
J
J
Partensky
C
C
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D021441:Carcinoma, Pancreatic Ductal / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D004386:Duodenum / Q000473:pathology; D006801:Humans; D007167:Immunotherapy; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D016577:Pancreaticoduodenectomy; D018714:Radiotherapy, Adjuvant; D011882:Radiotherapy, High-Energy; D017741:Survivors
D000911:Antibodies, Monoclonal